Your Article Summary
Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients
Metabolism-Clinical and Experimental, 06/30/09
Rossi R et al. - The authors' results are in line with the hypothesis that, among HIV-infected patients chronically treated with antiretroviral therapy, those with a larger brachial artery diameter are at high risk for metabolic disorders, including a more severe insulin resistance and the presence of metabolic syndrome.
Related Articles
Emergency Management of Inherited Metabolic Disorders
Topics in Clinical Nutrition, 11/16/09
Relevance Score: 69%
Treatment of Bipolar Disorders and Metabolic Syndrome: Implications for Primary Care
Postgraduate Medicine, 10/15/09
Relevance Score: 69%
Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders
Experimental Gerontology, 11/12/09
Relevance Score: 67%
Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome
Acta Diabetologia, 10/08/09
Relevance Score: 67%
Pharmacogenomic perspectives on the management of mood disorders
Psychiatric Bulletin, 10/02/09
Relevance Score: 67%
Today in HIV/Immunodeficiency...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-Term Complete Regression of Nodal Marginal Zone Lymphoma Transformed Into Diffuse Large B-Cell Lymphoma With Highly Active Antiretroviral Therapy Alone in Human Immunodeficiency Virus Infection
The American Journal of the Medical Sciences, 12/18/09
Temporal Reduction of HIV Type 1 Viral Load in Breast Milk by Single-Dose Nevirapine during Prevention of MTCT
AIDS Research and Human Retroviruses, 12/18/09
Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage
Journal of Clinical Virology, 12/18/09

See Latest Articles